Literature DB >> 24480579

Elevated protoporphyrin in patients with skin cancer receiving taxane chemotherapy.

Mai Tokunaga1, Natsuko Iga1, Yuichiro Endo1, Akihiro Fujisawa1, Miki Tanioka1, Kenji Kabashima1, Yoshiki Miyachi1.   

Abstract

BACKGROUND: Docetaxel and paclitaxel are both taxanes used for treatment of various malignant tumors. Only two case reports have described photohypersensitivity induced by docetaxel and paclitaxel in association with porphyrin aberrations.
OBJECTIVES: To examine whether aberrations in the biosynthesis of porphyrins and photohypersensitivity occur among patients receiving taxanes. MATERIALS &
METHODS: We examined porphyrin aberrations and photohypersensitivity in 8 patients with skin cancers who received docetaxel or paclitaxel chemotherapy in our department.
RESULTS: Aberrations in erythrocyte protoporphyrin were detected in 4 patients, while no such aberration was detected in the control group. Photohypersensitivity to Ultraviolet B (UVB) was detected in 2 patients; one was related to an elevated synthesis of protoporphyrin but the other was not. Photohypersensitivity to Ultraviolet A (UVA) or visible light was not detected.
CONCLUSION: Docetaxel and paclitaxel chemotherapy seemed to induce aberrations in porphyrin biosynthesis, although an elevated synthesis of porphyrin did not necessarily cause photohypersensitivity.

Entities:  

Keywords:  docetaxel; paclitaxel; protoporphyrin

Mesh:

Substances:

Year:  2013        PMID: 24480579     DOI: 10.1684/ejd.2013.2235

Source DB:  PubMed          Journal:  Eur J Dermatol        ISSN: 1167-1122            Impact factor:   3.328


  4 in total

Review 1.  Dermatological adverse events with taxane chemotherapy.

Authors:  Vincent Sibaud; Nicole R Lebœuf; Henri Roche; Viswanath R Belum; Laurence Gladieff; Marion Deslandres; Marion Montastruc; Audrey Eche; Emmanuelle Vigarios; Florence Dalenc; Mario E Lacouture
Journal:  Eur J Dermatol       Date:  2016-10-01       Impact factor: 3.328

2.  Nab-paclitaxel-associated photosensitivity: report in a woman with non-small cell lung cancer and review of taxane-related photodermatoses.

Authors:  Bryce D Beutler; Philip R Cohen
Journal:  Dermatol Pract Concept       Date:  2015-04-30

3.  Photodermatitis in a woman with infiltrating intraductal breast carcinoma: An uncommon adverse cutaneous drug reaction of paclitaxel revisited.

Authors:  Vikram K Mahajan; Vikas Sharma; Dhaarna Wadhwa
Journal:  Indian J Pharmacol       Date:  2020 Sep-Oct       Impact factor: 1.200

4.  Chemotherapy-associated paronychia treated with 2% povidone-iodine: a series of cases.

Authors:  Kara Capriotti; Joseph Capriotti; Jesse Pelletier; Kevin Stewart
Journal:  Cancer Manag Res       Date:  2017-06-26       Impact factor: 3.989

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.